Skip to content

Clinical trials

Phase 3 Stroke trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: Russia Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20053
20062
20071
20081
20091
20101
20112
20123
20136
20143
20152
20183
20193
20211
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated9
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Bayer3
Novartis Pharmaceuticals3
Pharmasoft3
Allergan2
Boehringer Ingelheim2
Janssen Research & Development, LLC2
Negovsky Reanimatology Research Institute2
Neurobiological Technologies2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke38
Myocardial Infarction10
Cardiovascular Diseases8
Atrial Fibrillation6
Ischemic Stroke6
Brain Ischemia4
Cerebrovascular Disorders4
Acute Coronary Syndrome3
Cerebral Palsy3
Coronary Artery Disease3

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.